Your browser doesn't support javascript.
loading
Most patients reported positively or neutrally of having served as controls in the trials within cohorts design.
Verweij, Maaike E; Gal, Roxanne; Burbach, J P Maarten; Young-Afat, Danny A; van der Velden, Joanne M; van der Graaf, Rieke; May, Anne M; Relton, Clare; Intven, Martijn P W; Verkooijen, Helena M.
Afiliação
  • Verweij ME; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Gal R; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Burbach JPM; Department of Surgery, University Medical Centre Groningen, Groningen, The Netherlands.
  • Young-Afat DA; Department of Plastic and Reconstructive Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • van der Velden JM; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • van der Graaf R; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Relton C; Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom.
  • Intven MPW; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Verkooijen HM; Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address: h.m.verkooijen@umcutrecht.nl.
J Clin Epidemiol ; 148: 39-47, 2022 08.
Article em En | MEDLINE | ID: mdl-35436526
OBJECTIVES: To evaluate patients' experience of having served as controls without a notification at the time of randomization in the context of the trial within cohorts (TwiCs) design. METHODS: Patients were asked for their opinion on having served as controls in TwiCs, before and after having been provided the trial results. Patients had provided broad consent to randomization at cohort entry and had served as controls in one of two TwiCs (an exercise program after breast cancer treatment or radiotherapy dose-escalation for rectal cancer). RESULTS: Two to 6 years after cohort entry, 15% (n = 16) of all patients remembered having provided broad consent to randomization. Before disclosure of trial results, 47% (n = 52) of patients thought positively, 45% (n = 50) neutrally, and 2% (n = 2) negatively of having served as controls in one of the two trials. Seventeen percent (n = 18) of patients were positive, 65% (n = 71) neutral, and 11% (n = 12) negative about not having been notified when serving as controls. The survey results were comparable after disclosure of trial results. CONCLUSIONS: These results support the use of the TwiCs design with the staged-informed consent procedure. Keeping patients engaged and aware of the consents provided might further improve patients' experience of serving as controls in TwiCs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Consentimento Livre e Esclarecido Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Consentimento Livre e Esclarecido Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article